DK0876394T3 - Fremstilling af (11beta, 16beta)-21-(acetyloxy)-11-hydroxy-2'-methyl-5'H-pregna-1,4-dieno[17,16-d]oxazol-3,20-dion - Google Patents

Fremstilling af (11beta, 16beta)-21-(acetyloxy)-11-hydroxy-2'-methyl-5'H-pregna-1,4-dieno[17,16-d]oxazol-3,20-dion

Info

Publication number
DK0876394T3
DK0876394T3 DK96942323T DK96942323T DK0876394T3 DK 0876394 T3 DK0876394 T3 DK 0876394T3 DK 96942323 T DK96942323 T DK 96942323T DK 96942323 T DK96942323 T DK 96942323T DK 0876394 T3 DK0876394 T3 DK 0876394T3
Authority
DK
Denmark
Prior art keywords
dieno
pregna
oxazole
dione
methyl
Prior art date
Application number
DK96942323T
Other languages
Danish (da)
English (en)
Inventor
Luigi Forte
Calogero Cancellieri
Original Assignee
Lepetit Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lepetit Spa filed Critical Lepetit Spa
Application granted granted Critical
Publication of DK0876394T3 publication Critical patent/DK0876394T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J71/00—Steroids in which the cyclopenta(a)hydrophenanthrene skeleton is condensed with a heterocyclic ring
    • C07J71/0036—Nitrogen-containing hetero ring
    • C07J71/0057—Nitrogen and oxygen
    • C07J71/0068—Nitrogen and oxygen at position 16(17)
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J71/00—Steroids in which the cyclopenta(a)hydrophenanthrene skeleton is condensed with a heterocyclic ring

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
DK96942323T 1995-12-13 1996-12-04 Fremstilling af (11beta, 16beta)-21-(acetyloxy)-11-hydroxy-2'-methyl-5'H-pregna-1,4-dieno[17,16-d]oxazol-3,20-dion DK0876394T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP95119626 1995-12-13
PCT/EP1996/005390 WO1997021722A1 (en) 1995-12-13 1996-12-04 PREPARATION OF (11β,16β)-21-(ACETYLOXY)-11-HYDROXY-2'-METHYL-5'H-PREGNA-1,4-DIENO[17,16-D]OXAZOLE-3,20-DIONE

Publications (1)

Publication Number Publication Date
DK0876394T3 true DK0876394T3 (da) 2001-08-06

Family

ID=8219882

Family Applications (1)

Application Number Title Priority Date Filing Date
DK96942323T DK0876394T3 (da) 1995-12-13 1996-12-04 Fremstilling af (11beta, 16beta)-21-(acetyloxy)-11-hydroxy-2'-methyl-5'H-pregna-1,4-dieno[17,16-d]oxazol-3,20-dion

Country Status (16)

Country Link
US (1) US6103895A (ja)
EP (1) EP0876394B1 (ja)
JP (1) JP4016070B2 (ja)
KR (1) KR100453029B1 (ja)
CN (1) CN100358914C (ja)
AT (1) ATE201213T1 (ja)
AU (1) AU707409B2 (ja)
CA (1) CA2238691C (ja)
DE (1) DE69612871T2 (ja)
DK (1) DK0876394T3 (ja)
ES (1) ES2157476T3 (ja)
GR (1) GR3035988T3 (ja)
HK (1) HK1017691A1 (ja)
PT (1) PT876394E (ja)
WO (1) WO1997021722A1 (ja)
ZA (1) ZA9610412B (ja)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PT879242E (pt) * 1995-12-13 2000-10-31 Lepetit Spa Preparacao de (11beta,16beta)-21-(3-carboxi-3-oxopropoxi)-11-hidroxi-2'-metil-5'h-pregna-1,4-dieno¬17,16-d|oxazole-3,20-diona
CN106008660B (zh) * 2016-06-20 2018-02-23 湖南科瑞生物制药股份有限公司 地夫可特的制备方法
CN107488203B (zh) * 2017-08-30 2019-06-04 湖南科瑞生物制药股份有限公司 一种16a-羟基泼尼松龙的制备方法
EP4230196A1 (en) 2022-02-21 2023-08-23 Som Innovation Biotech, S.A. Compounds for use in the treatment of dystrophinopathies

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE250538C (ja) *
DD250538A1 (de) * 1984-12-11 1987-10-14 Jenapharm Veb Verfahren zur selektiven acetylierung von hydroxy-steroidcarbonsaeuren
GB8730216D0 (en) * 1987-12-29 1988-02-03 Lepetit Spa Process for preparation of pregnenooxazolines
PT879242E (pt) * 1995-12-13 2000-10-31 Lepetit Spa Preparacao de (11beta,16beta)-21-(3-carboxi-3-oxopropoxi)-11-hidroxi-2'-metil-5'h-pregna-1,4-dieno¬17,16-d|oxazole-3,20-diona

Also Published As

Publication number Publication date
AU1175697A (en) 1997-07-03
PT876394E (pt) 2001-08-30
ATE201213T1 (de) 2001-06-15
JP2000503632A (ja) 2000-03-28
JP4016070B2 (ja) 2007-12-05
CN100358914C (zh) 2008-01-02
WO1997021722A1 (en) 1997-06-19
ZA9610412B (en) 1997-07-23
DE69612871D1 (de) 2001-06-21
EP0876394A1 (en) 1998-11-11
KR19990072026A (ko) 1999-09-27
CA2238691C (en) 2004-07-20
US6103895A (en) 2000-08-15
KR100453029B1 (ko) 2004-12-17
ES2157476T3 (es) 2001-08-16
GR3035988T3 (en) 2001-08-31
AU707409B2 (en) 1999-07-08
DE69612871T2 (de) 2001-10-04
EP0876394B1 (en) 2001-05-16
HK1017691A1 (en) 1999-11-26
CN1204339A (zh) 1999-01-06
CA2238691A1 (en) 1997-06-19

Similar Documents

Publication Publication Date Title
CY2009010I2 (el) Μεθοδος για εμπλουτισμο r-επιμερους 16,17-ακεταλης παραγωγων των 21-ακυλοξυ πρεγνα-1,4-διεν-11.βητα., 16.αλφα., 17.αλφα.-τριολ-3,20-διονης
DE122005000030I1 (de) Pregna-1, 4-dien-3, 20-dion-16-17-acetal-21-ester,Verfahren zur Herstellung, sowie diese enthaltendepharmazeutische Pr{parate.
ATE166577T1 (de) Glykosylierte steroid derivate für den transport durch biologische membranen und verfahren zu deren herstellung
ES2132249T3 (es) Procedimiento de preparacion de pregnanos 3-alfa-hidroxi,3-beta sustituidos.
GEP20012530B (en) Neuroactive Steroids of the Androstane and Pregnane Series
DK0876394T3 (da) Fremstilling af (11beta, 16beta)-21-(acetyloxy)-11-hydroxy-2'-methyl-5'H-pregna-1,4-dieno[17,16-d]oxazol-3,20-dion
PT78743A (de) 1-alkyl-androsta-1,4-dien-3,17-dione verfahren zu deren herstellung und diese enthaltende pharmazeutische praeparate
CA2394731A1 (en) Process for preparing 17alpha-acetoxy-11beta-[4-n,n-(dimethylamino)phenyl]-21-methoxy-19-norpregna-4,9-diene-3,20-dione, intermediates useful in the process, and processes for preparing such intermediates
DK0923599T3 (da) Fremgangsmåde til fremstilling af 17-estere af 9alfa, 21-dihalogenpregnan-11beta, 17alfa-diol-20-oner
ATE1710T1 (de) Verfahren zur herstellung von chenodeoxycholsaeure und zwischenprodukte dazu.
DE69310052T2 (de) Kardioaktive 17B-(3-Furyl) und 17B-(4-Pyridazinyl)-5beta, 14beta-Androstan Derivate, Verfahren zu ihrer Herstellung und pharmazeutische Präparate davon
NO20031964D0 (no) Fremgangsmåte for fremstilling av 16,17- [(cykloheksylmetylen)bis(oksy)]-11,21-dihydroksy-pregna-1,4-dien-3,20-dion eller dets 21-isobutyratved transketalisering
NO982413L (no) Fremstilling av (11<beta>, 16<beta>)-21-(3-karboksy-3-oksypropoksy)-11-hydroksy-2'-metyl-5'H-pregna-1,4-dieno£17,16-d|oksazol-3,20-dion
HUT64365A (en) Process for steroid aromatase inhibitors containing 2-beta, 19-methylene-amino bridge and pharmaceutical preparatives containing them
Cooley et al. 802. Modified steroid hormones. Part XXIII. Some pentacyclic types
ATE73136T1 (de) Verfahren zur herstellung von 6alpha, 9alphadifluor-11beta, 17alpha-dihydroxy-16alpha-methyl4-pregnen-3,20-dion und dessen derivate.
Vernon et al. C-3 glucosiduronates of metabolites of adrenal steroids
EP0136465A3 (en) Process for the preparation of 17-alpha-acetoxy-1-alpha, 2-alpha-methylene-pregna-4,6-diene-3,20 dione
岩井重久 A Note on “Anaerobic Digestion and Utilization of Digester Gas”
DK0885240T3 (da) Fremgangsmåde til rensning af 11beta-21-dihydroxy-2' -methyl-5'betaH-pregna-1, 4-dieno[17,16-d] oxazol-3,20-dion
GB1082679A (en) Process for the manufacture of a-nor-b-homo-steroids and steroid intermediates therefor
DK0879242T3 (da) Fremstilling af (11alpha, 16alpha)-21-(3-carboxy-3-oxopropoxy)-11-hydroxy-2'-methyl-5'H-pregna-1,4-dieno(17,16-d)oxazol-3,2